Medgend Icon







discontinued


Brimonidine Tartrate FDA Approved Drugs

ALPHAGAN P [Brimonidine TartrateC11H10BrN5C4H6O6]
RX
-
0.1% (ophthalmic solution/drops)
0.15% (ophthalmic solution/drops)
AllerganAug 19, 2005
  • Reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
efficacy
0.0  (0)
side effects
2.0  (1)
danger
2.0  (1)

UNK

BRIMONIDINE TARTRATE [Brimonidine TartrateC11H10BrN5C4H6O6]
RX
-
0.2% (ophthalmic solution/drops)
AkornMar 14, 2006
Bausch And LombMay 28, 2003
Indoco RemediesNov 18, 2014
Sandoz IncJan 30, 2008
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

COMBIGAN [Brimonidine TartrateC11H10BrN5C4H6O6 : Timolol MaleateC13H24N4O3SC4H4O4]
RX
-
0.2% : eq 0.5% base (ophthalmic solution/drops)
AllerganOct 30, 2007
  • Reduction of elevated intraocular pressure (iop) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled iop. dose is one drop of combigan in the affected eye twice daily.
  • Reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled iop.
  • Reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension.
  • Reduction of elevated intraocular pressure.
  • Reduction of intraocular pressure in patients with elevated intraocular pressure or glaucoma.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MIRVASO [Brimonidine TartrateC11H10BrN5C4H6O6]
RX
-
eq 0.33% base (topical gel)
Galderma Labs LpAug 23, 2013
  • Topical treatment of facial erythema of rosacea.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

QOLIANA [Brimonidine TartrateC11H10BrN5C4H6O6]
RX
-
0.15% (ophthalmic solution/drops)
Sandoz IncMay 22, 2006
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SIMBRINZA [Brimonidine TartrateC11H10BrN5C4H6O6 : BrinzolamideC12H21N3O5S3]
RX
-
0.2% : 1% (ophthalmic suspension/drops)
Novartis Pharms CorpApr 19, 2013
  • Reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.